uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Biochemistry and Microbiology. Broad Inst, Cambridge, MA 02142 USA..
Broad Inst, Cambridge, MA 02142 USA..
Broad Inst, Cambridge, MA 02142 USA..
Broad Inst, Cambridge, MA 02142 USA..
Show others and affiliations
2015 (English)In: Genome Research, ISSN 1088-9051, E-ISSN 1549-5469, Vol. 25, no 11, 1634-1645 p.Article in journal (Refereed) PublishedText
Abstract [en]

Lymphoma is the most common hematological malignancy in developed countries. Outcome is strongly determined by molecular subtype, reflecting a need for new and improved treatment options. Dogs spontaneously develop lymphoma, and the predisposition of certain breeds indicates genetic risk factors. Using the dog breed structure, we selected three lymphoma predisposed breeds developing primarily T-cell (boxer), primarily B-cell (cocker spaniel), and with equal distribution of B- and T-cell lymphoma (golden retriever), respectively. We investigated the somatic mutations in B- and T-cell lymphomas from these breeds by exome sequencing of tumor and normal pairs. Strong similarities were evident between B-cell lymphomas from golden retrievers and cocker spaniels, with recurrent mutations in TRAF3-MAP3K14 (28% of all cases), FBXW7 (25%), and POT1 (17%). The FBXW7 mutations recurrently occur in a specific codon; the corresponding codon is recurrently mutated in human cancer. In contrast, T-cell lymphomas from the predisposed breeds, boxers and golden retrievers, show little overlap in their mutation pattern, sharing only one of their 15 most recurrently mutated genes. Boxers, which develop aggressive T-cell lymphomas, are typically mutated in the PTEN-mTOR pathway. T-cell lymphomas in golden retrievers are often less aggressive, and their tumors typically showed mutations in genes involved in cellular metabolism. We identify genes with known involvement in human lymphoma and leukemia, genes implicated in other human cancers, as well as novel genes that could allow new therapeutic options.

Place, publisher, year, edition, pages
2015. Vol. 25, no 11, 1634-1645 p.
National Category
Biochemistry and Molecular Biology Cancer and Oncology
URN: urn:nbn:se:uu:diva-268799DOI: 10.1101/gr.194449.115ISI: 000364355600005PubMedID: 26377837OAI: oai:DiVA.org:uu-268799DiVA: diva2:881108
NIH (National Institute of Health), U54 HG003067-08EU, European Research CouncilSwedish Research CouncilEU, European Research Council
Available from: 2015-12-09 Created: 2015-12-09 Last updated: 2015-12-09Bibliographically approved

Open Access in DiVA

fulltext(579 kB)113 downloads
File information
File name FULLTEXT01.pdfFile size 579 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Elvers, IngegerdLindblad-Toh, Kerstin
By organisation
Department of Medical Biochemistry and Microbiology
In the same journal
Genome Research
Biochemistry and Molecular BiologyCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 113 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 211 hits
ReferencesLink to record
Permanent link

Direct link